HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J To Remove Formaldehyde, Other Concerns From Personal-Care Items

This article was originally published in The Rose Sheet

Executive Summary

In response to consumer demand, J&J will remove controversial ingredients from both baby and adult brands, including Neutrogena, Aveeno, Lubriderm and Clean & Clear.

You may also be interested in...



FDA Rule Marks Consumer Antibac Soaps A Possible Endangered Species

FDA’s rule “clarifies the mission” for manufacturers of consumer antibacterial soaps, which have a year to demonstrate that they are safe and effective or risk losing the entire OTC drug category.

FDA Rule Marks Consumer Antibacterial Soaps An Endangered Category

FDA’s final rule “clarifies the mission” for manufacturers of consumer antibacterial soaps, which have a year to demonstrate that benzalkonium chloride, benzethonium chloride and chloroxylenol are safe and effective or risk losing the entire OTC drug category. The rule bars firms from marketing consumer antiseptic wash products containing triclosan, triclocarban and 17 other lesser-used active ingredients.

ICCR Adds Cosmetic Product Preservation To Agenda For Ninth Meeting

During a public preparatory meeting in advance of the ninth International Cooperation for Cosmetics Regulation summit, FDA Office of Cosmetics and Colors Director Linda Katz said that the topic of cosmetic product preservation will be included on the agenda for the first time. Animal-testing alternatives, allergens and trace impurities also are up for discussion, continuing regulators' work from last year on those topics.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018241

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel